Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
Active, not recruiting · NCT05218668 · Registry updated 2025-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL) | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Phase 2 | 2025-04-08 | NCT05218668 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Woolsey Pharmaceuticals | 1 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Calvary Health Bethlehem Hospital | Melbourne | Australia | 1 |
| Cox Medical Center | Springfield | United States | 3 |
| Hospital for Special Surgery | New York | United States | 106 |
| Lakes Research | Miami Lakes | United States | 3 |
| Macquarie University Hospital | Sydney | Australia | 1 |
| National Jewish Health | Denver | United States | 72 |
| Neuromuscular Research Center | Phoenix | United States | 3 |
| Northwestern University | Chicago | United States | 727 |
| Royal Brisbane and Women's Hospital | Brisbane | Australia | 1 |
| University of Colorado | Aurora | United States | 147 |
| University of Kentucky | Lexington | United States | 65 |
| University of South Florida | Tampa | United States | 33 |